The company added just 73 000 net subscribers while spending $218 million on marketinga marginal decline from $231 million in Q1
Wegovy, another medication with semaglutide as the main active ingredient, is an FDA-approved medication designed to help adults struggling with obesity or excess weight
With the introduction of dual GLP-1/GIP-RA, ongoing studies could provide novel insights and new evidence on this topic
Among the outcome estimates, significant reductions were reported in 13 of 17 for major adverse cardiovascular events (MACE), 5 of 8 for cardiovascular mortality, 3 of 4 for cardiovascular disease (CVD) events, 1 of 3 for cardiovascular death, and 1 of 1 for composite cardiovascular outcomes
Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial
If youre looking for a Best Weight Loss Doctor in Ahmedabad or an Endocrinologist in Ahmedabad , Dr